The company expired its plan on November 17, 2022
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,565 KRW | +0.51% | -2.00% | -8.05% |
2023 | Wonbiogen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Tranche Update on Wonbiogen Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022. | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.05% | 40.29M | |
+8.91% | 27.39B | |
-41.00% | 2.63B | |
+26.30% | 2.48B | |
+5.99% | 2.21B | |
+24.44% | 1.91B | |
-14.16% | 1.81B | |
+33.51% | 1.34B | |
+25.56% | 1.32B | |
-2.45% | 1.25B |
- Stock Market
- Equities
- A307280 Stock
- News Wonbiogen Co., Ltd.
- Wonbiogen Co., Ltd.'s Equity Buyback announced on May 16, 2022, has expired with 1,485,877 shares, for KRW 2,995.7 million.